Dr. Reddy's Laboratories Limited (BOM: 500124)

Dr. Reddy's Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Revenue	299,867	279,164	245,879	214,391	189,722	174,600
Revenue Growth (YoY)	12.37%	13.54%	14.69%	13.00%	8.66%	13.49%
Cost of Revenue	122,068	115,557	106,536	100,551	86,645	80,591
Gross Profit	177,799	163,607	139,343	113,840	103,077	94,009
Selling, General & Admin	86,402	77,201	68,026	62,081	54,650	50,129
Research & Development	25,906	22,873	19,381	17,482	16,541	15,410
Other Operating Expenses	-2,175	-1,775	-1,480	-1,642	-1,024	-843
Operating Expenses	110,133	98,299	85,927	77,921	70,167	64,696
Operating Income	67,666	65,308	53,416	35,919	32,910	29,313
Interest Expense	-2,342	-1,711	-1,428	-958	-970	-983
Interest & Investment Income	2,639	2,278	1,180	965	826	888
Earnings From Equity Investments	182	147	370	703	480	561
Currency Exchange Gain (Loss)	213	278	2,225	1,835	1,240	639
Other Non Operating Income (Expenses)	764	46	-152	277	557	5
EBT Excluding Unusual Items	69,122	66,346	55,611	38,741	35,043	30,423
Gain (Loss) on Sale of Investments	3,103	3,103	1,028	-	-	929
Gain (Loss) on Sale of Assets	902	900	-1,211	1,119	-42	-10
Asset Writedown	-866	-3	-699	-7,562	-8,588	-16,767
Legal Settlements	-	1,524	5,638	-	-	-
Other Unusual Items	-	-	-	-	-	3,457
Pretax Income	72,261	71,870	60,367	32,298	26,413	18,032
Income Tax Expense	18,067	16,186	15,300	8,730	9,175	-1,466
Earnings From Continuing Operations	54,194	55,684	45,067	23,568	17,238	19,498
Minority Interest in Earnings	-862	-	-	-	-	-
Net Income	53,332	55,684	45,067	23,568	17,238	19,498
Net Income to Common	53,332	55,684	45,067	23,568	17,238	19,498
Net Income Growth	4.80%	23.56%	91.22%	36.72%	-11.59%	3.74%
Shares Outstanding (Basic)	833	832	830	829	829	829
Shares Outstanding (Diluted)	834	834	832	832	832	830
Shares Change (YoY)	0.16%	0.19%	0.03%	0.01%	0.14%	-0.07%
EPS (Basic)	64.05	66.93	54.29	28.42	20.79	23.53
EPS (Diluted)	63.95	66.80	54.17	28.34	20.73	23.48
EPS Growth	4.63%	23.32%	91.16%	36.70%	-11.71%	3.81%
Free Cash Flow	12,343	29,030	47,552	13,448	25,962	24,995
Free Cash Flow Per Share	14.80	34.83	57.16	16.17	31.22	30.10
Dividend Per Share	8.000	8.000	8.000	6.000	5.000	5.000
Dividend Growth	0%	0%	33.33%	20.00%	0%	25.00%
Gross Margin	59.29%	58.61%	56.67%	53.10%	54.33%	53.84%
Operating Margin	22.57%	23.39%	21.72%	16.75%	17.35%	16.79%
Profit Margin	17.79%	19.95%	18.33%	10.99%	9.09%	11.17%
Free Cash Flow Margin	4.12%	10.40%	19.34%	6.27%	13.68%	14.32%
EBITDA	81,791	79,006	65,173	47,743	45,706	41,785
EBITDA Margin	27.28%	28.30%	26.51%	22.27%	24.09%	23.93%
D&A For EBITDA	14,125	13,698	11,757	11,824	12,796	12,472
EBIT	67,666	65,308	53,416	35,919	32,910	29,313
EBIT Margin	22.57%	23.39%	21.72%	16.75%	17.35%	16.79%
Effective Tax Rate	25.00%	22.52%	25.34%	27.03%	34.74%	-

Source: S&P Capital IQ. Standard template. Financial Sources.